31. Genomewide association study on monoclonal gammopathy of unknown significance (MGUS). (24th May 2017) Authors: Thomsen, Hauke; Campo, Chiara; Weinhold, Niels; da Silva Filho, Miguel Inacio; Pour, Luděk; Gregora, Evžen; Vodicka, Pavel; Vodickova, Ludmila; Hoffmann, Per; Nöthen, Markus M; Jöckel, Karl‐Heinz; Langer, Christian; Hajek, Roman; Goldschmidt, Hartmut; Hemminki, Kari; Försti, Asta Journal: European journal of haematology Issue: Volume 99:Number 1(2017) Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Genomewide profiling of copy‐number alteration in monoclonal gammopathy of undetermined significance. (9th June 2016) Authors: Mikulasova, Aneta; Smetana, Jan; Wayhelova, Marketa; Janyskova, Helena; Sandecka, Viera; Kufova, Zuzana; Almasi, Martina; Jarkovsky, Jiri; Gregora, Evzen; Kessler, Petr; Wrobel, Marek; Walker, Brian A.; Wardell, Christopher P.; Morgan, Gareth J.; Hajek, Roman; Kuglik, Petr Journal: European journal of haematology Issue: Volume 97:Number 6(2016:Dec.) Page Start: 568 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Identification of patients at high risk of secondary extramedullary multiple myeloma development. (2nd November 2021) Authors: Stork, Martin; Sevcikova, Sabina; Minarik, Jiri; Krhovska, Petra; Radocha, Jakub; Pospisilova, Lenka; Brozova, Lucie; Jarkovsky, Jiri; Spicka, Ivan; Straub, Jan; Pavlicek, Petr; Jungova, Alexandra; Jelinek, Tomas; Sandecka, Viera; Maisnar, Vladimir; Hajek, Roman; Pour, Ludek Journal: British journal of haematology Issue: Volume 196:Number 4(2022) Page Start: 954 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Identifying and treating candidates for checkpoint inhibitor therapies in multiple myeloma and lymphoma. Issue 4 (2nd April 2020) Authors: Hradska, Katarina; Kascak, Michal; Hajek, Roman; Jelinek, Tomas Journal: Expert review of hematology Issue: Volume 13:Issue 4(2020) Page Start: 375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. IgM myeloma: A multicenter retrospective study of 134 patients. Issue 8 (26th May 2017) Authors: Castillo, Jorge J.; Jurczyszyn, Artur; Brozova, Lucie; Crusoe, Edvan; Czepiel, Jacek; Davila, Julio; Dispenzieri, Angela; Eveillard, Marion; Fiala, Mark A.; Ghobrial, Irene M.; Gozzetti, Alessandro; Gustine, Joshua N.; Hajek, Roman; Hungria, Vania; Jarkovsky, Jiri; Jayabalan, David; Laubach, Jaco... Journal: American journal of hematology Issue: Volume 92:Issue 8(2017:Aug.) Page Start: 746 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis. Issue 1 (4th June 2022) Authors: Dimopoulos, Meletios A.; Moreau, Philippe; Augustson, Bradley; Castro, Nelson; Pika, Tomas; Delimpasi, Sosana; De la Rubia, Javier; Maiolino, Angelo; Reiman, Tony; Martinez‐Lopez, Joaquin; Martin, Thomas; Mikhael, Joseph; Yong, Kwee; Risse, Marie‐Laure; Asset, Gaelle; Marion, Sylvia; Hajek, Roman Journal: American journal of hematology Issue: Volume 98:Issue 1(2023) Page Start: E15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial. Issue 10292 (19th June 2021) Authors: Moreau, Philippe; Dimopoulos, Meletios-Athanasios; Mikhael, Joseph; Yong, Kwee; Capra, Marcelo; Facon, Thierry; Hajek, Roman; Špička, Ivan; Baker, Ross; Kim, Kihyun; Martinez, Gracia; Min, Chang-Ki; Pour, Ludek; Leleu, Xavier; Oriol, Albert; Koh, Youngil; Suzuki, Kenshi; Risse, Marie-Laure; Asset... Journal: Lancet Issue: Volume 397:Issue 10292(2021) Page Start: 2361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Melflufen for relapsed and refractory multiple myeloma. (2nd October 2020) Authors: Oriol, Albert; Larocca, Alessandra; Leleu, Xavier; Hajek, Roman; Hassoun, Hani; Rodríguez-Otero, Paula; Paner, Agne; Schjesvold, Fredrik H.; Gullbo, Joachim; Richardson, Paul G. Journal: Expert opinion on investigational drugs Issue: Volume 29:Number 10(2020) Page Start: 1069 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study. Issue 2 (February 2022) Authors: Schjesvold, Fredrik H; Dimopoulos, Meletios-Athanasios; Delimpasi, Sosana; Robak, Pawel; Coriu, Daniel; Legiec, Wojciech; Pour, Luděk; Špička, Ivan; Masszi, Tamas; Doronin, Vadim; Minarik, Jiri; Salogub, Galina; Alekseeva, Yulia; Lazzaro, Antonio; Maisnar, Vladimir; Mikala, Gábor; Rosiñol, Laura;... Journal: Lancet Issue: Volume 9:Issue 2(2022) Page Start: e98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Molecular heterogeneity and centrosome-associated genes in multiple myeloma. Issue 9 (September 2013) Authors: Kryukov, Fedor; Nemec, Pavel; Dementyeva, Elena; Kubiczkova, Lenka; Ihnatova, Ivana; Budinska, Eva; Jarkovsky, Jiri; Sevcikova, Sabina; Kuglik, Petr; Hajek, Roman Journal: Leukemia & lymphoma Issue: Volume 54:Issue 9(2013:Sep.) Page Start: 1982 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗